Sonoma Pharmaceuticals Inc
SNOA
$1.12+0.00%
End of day · as of Oct 17, 2026, 7:30 AM ET
Mkt cap
$4.88M
EV/Sales
N/A
P/E ratio
N/A
FY2026 Revenue
$19.53M
EPS (9mo ended 2025-12-31)
$-1.56
Gross Margin (FY2026)
37.97%
Profit Margin (FY2026)
-16.26%
Beta
1.40
Div yield
N/A
Sector
Healthcare
Sonoma Pharmaceuticals Inc (SNOA) is a drug manufacturers - specialty & generic company listed on US.
Latest reported SNOA revenue for 2026-03-31 was $19.5M. Net income was -$3.2M. Revenue was up 36.7% from 2025-03-31 to 2026-03-31. SNOA currently screens at market cap $4.9M.
Use this SNOA research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full SNOA income, balance, and cash tables.
Sonoma Pharmaceuticals Inc (SNOA) is a drug manufacturers - specialty & generic company in the Healthcare sector.
Latest cached Sonoma Pharmaceuticals Inc (SNOA) revenue for Mar 31, 2026 was $19.5M. Net income was -$3.2M. Statements: https://lician.com/financials/snoa
Sonoma Pharmaceuticals Inc (SNOA) market capitalization is $4.9M on the latest cached snapshot.
Sonoma Pharmaceuticals Inc (SNOA) cached previous close $1.12; day range $1.12 – $1.23; volume 56,784. Session quote: https://lician.com/quote/snoa
Sonoma Pharmaceuticals Inc (SNOA) latest cached earnings event is "SNOA earnings" on Aug 6, 2026. Earnings calendar: https://lician.com/earnings
The latest cached SNOA filing is 8-K · Oct 6, 2026. Filings: https://lician.com/sec/snoa